1. Home
  2. PTCT vs MRCY Comparison

PTCT vs MRCY Comparison

Compare PTCT & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • MRCY
  • Stock Information
  • Founded
  • PTCT 1998
  • MRCY 1981
  • Country
  • PTCT United States
  • MRCY United States
  • Employees
  • PTCT N/A
  • MRCY N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • MRCY
  • Sector
  • PTCT Health Care
  • MRCY
  • Exchange
  • PTCT Nasdaq
  • MRCY Nasdaq
  • Market Cap
  • PTCT 5.3B
  • MRCY 4.6B
  • IPO Year
  • PTCT 2013
  • MRCY 1998
  • Fundamental
  • Price
  • PTCT $71.75
  • MRCY $75.33
  • Analyst Decision
  • PTCT Buy
  • MRCY Buy
  • Analyst Count
  • PTCT 17
  • MRCY 8
  • Target Price
  • PTCT $73.24
  • MRCY $72.13
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • MRCY 613.1K
  • Earning Date
  • PTCT 11-04-2025
  • MRCY 11-04-2025
  • Dividend Yield
  • PTCT N/A
  • MRCY N/A
  • EPS Growth
  • PTCT N/A
  • MRCY N/A
  • EPS
  • PTCT 8.94
  • MRCY N/A
  • Revenue
  • PTCT $1,779,150,000.00
  • MRCY $932,798,000.00
  • Revenue This Year
  • PTCT $119.02
  • MRCY $6.17
  • Revenue Next Year
  • PTCT N/A
  • MRCY $8.23
  • P/E Ratio
  • PTCT $8.03
  • MRCY N/A
  • Revenue Growth
  • PTCT 97.54
  • MRCY 8.63
  • 52 Week Low
  • PTCT $35.95
  • MRCY $37.28
  • 52 Week High
  • PTCT $73.98
  • MRCY $85.33
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 72.03
  • MRCY 46.86
  • Support Level
  • PTCT $66.10
  • MRCY $74.07
  • Resistance Level
  • PTCT $69.88
  • MRCY $79.92
  • Average True Range (ATR)
  • PTCT 2.47
  • MRCY 2.71
  • MACD
  • PTCT 0.05
  • MRCY -0.46
  • Stochastic Oscillator
  • PTCT 72.70
  • MRCY 20.53

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: